2005
Quantitative DNA perturbations of p53 in endometriosis: analysis of American and Icelandic cases
Gylfason J, Dang D, Petursdottir V, Benediktsdottir K, Geirsson R, Poindexter A, Mitchell-Leef D, Buster J, Carson S, Simpson J, Bischoff F. Quantitative DNA perturbations of p53 in endometriosis: analysis of American and Icelandic cases. Fertility And Sterility 2005, 84: 1388-1394. PMID: 16275233, DOI: 10.1016/j.fertnstert.2005.05.031.Peer-Reviewed Original ResearchConceptsPolymerase chain reactionUnaffected controlsSevere stage endometriosisReal-time polymerase chain reactionFresh surgical tissuesSevere endometriosisEndometriotic tissueMAIN OUTCOMEQuantitative aberrationsControl bloodSurgical tissuesP53 valuesTissue specimensLocus alterationsEndometriosisP53 lossP53 gainChain reactionSignificant differencesGAPDH controlTissueP53Copy numberAmerican subjectsPrevalence of premature urinary luteinizing hormone surges in women with regular menstrual cycles and its effect on implantation of frozen-thawed embryos
Krotz S, McKenzie L, Cisneros P, Buster J, Amato P, Carson S. Prevalence of premature urinary luteinizing hormone surges in women with regular menstrual cycles and its effect on implantation of frozen-thawed embryos. Fertility And Sterility 2005, 83: 1742-1744. PMID: 15950645, DOI: 10.1016/j.fertnstert.2004.11.078.Peer-Reviewed Original ResearchConceptsPremature LH surgeRegular menstrual cyclesFrozen embryo transferLH surgeEmbryo transferUrinary LHMenstrual cyclePregnancy rateNatural cycle frozen embryo transferFrozen-thawed embryo transferAssisted reproductive technology programRetrospective cohort studyReproductive technology programFrozen-thawed embryosCohort studyPregnancy outcomesMenstruating womenHormone surgePremature LHMAIN OUTCOMEMedical CollegePrivate medical collegeLHWomenRIA kit
2004
Characterizing ectopic pregnancies that rupture despite treatment with methotrexate
Dudley P, Heard M, Sangi-Haghpeykar H, Carson S, Buster J. Characterizing ectopic pregnancies that rupture despite treatment with methotrexate. Fertility And Sterility 2004, 82: 1374-1378. PMID: 15533363, DOI: 10.1016/j.fertnstert.2004.03.066.Peer-Reviewed Original ResearchConceptsTubal ruptureEctopic pregnancyRisk factorsHCG valuesHuman chorionic gonadotropin valuesRetrospective case-control analysisIndependent risk factorUrban medical centerCase-control analysisConcentrations of hCGEctopic gestationMTX administrationIndependent predictorsSurgical interventionGonadotropin valuesHCG concentrationsMAIN OUTCOMEMedical CenterMethotrexateImplantation sitesPregnancyTubal isthmusPatientsPredictive variablesTreatmentAbsence of secretory endometrium after false-positive home urine luteinizing hormone testing
McGovern P, Myers E, Silva S, Coutifaris C, Carson S, Legro R, Schlaff W, Carr B, Steinkampf M, Giudice L, Leppert P, Diamond M, Network N. Absence of secretory endometrium after false-positive home urine luteinizing hormone testing. Fertility And Sterility 2004, 82: 1273-1277. PMID: 15533341, DOI: 10.1016/j.fertnstert.2004.03.070.Peer-Reviewed Original ResearchConceptsProportion of casesEndometrial biopsyProliferative endometriumLH testingHealth/National InstituteReproductive Medicine NetworkEvaluation of infertilityRegular menstrual cyclesAdditional confirmatory testingMulticenter clinical trialLate luteal phaseNational InstituteFalse-positive testsInfertile womenHormone testingSecretory endometriumMenstrual cycleClinical trialsLH testLuteal phaseInfertile couplesMAIN OUTCOMEChild healthFertile volunteersClinical practicePregnancy outcome of in vitro fertilization/intracytoplasmic sperm injection with profound teratospermia
McKenzie L, Kovanci E, Amato P, Cisneros P, Lamb D, Carson S. Pregnancy outcome of in vitro fertilization/intracytoplasmic sperm injection with profound teratospermia. Fertility And Sterility 2004, 82: 847-849. PMID: 15482758, DOI: 10.1016/j.fertnstert.2004.03.054.Peer-Reviewed Original ResearchConceptsIntracytoplasmic sperm injectionIVF/intracytoplasmic sperm injectionPregnancy outcomesSperm injectionFertilization/intracytoplasmic sperm injectionIVF/ICSI cyclesTertiary care centerAppropriate developmental milestonesBirth defectsStrict criteriaTime of deliveryKruger's strict criteriaYears of ageAcceptable pregnancy ratesOvarian stimulationICSI cyclesIncreased riskCare centerPregnancy rateRetrospective analysisMAIN OUTCOMETransvaginal aspirationEmbryo transferInfant statusSmall series
2002
Pregnancies following use of metformin for ovulation induction in patients with polycystic ovary syndrome
Heard M, Pierce A, Carson S, Buster J. Pregnancies following use of metformin for ovulation induction in patients with polycystic ovary syndrome. Fertility And Sterility 2002, 77: 669-673. PMID: 11937113, DOI: 10.1016/s0015-0282(01)03266-6.Peer-Reviewed Original ResearchConceptsPolycystic ovary syndromeOvary syndromeSpontaneous abortionDiagnosis of PCOSAnovulatory infertility patientsUse of metforminResumption of mensesGastrointestinal-related side effectsEvidence of ovulationDosage of metforminAnovulatory patientsMetformin therapyPCOS resultsClomiphene citrateOvulation inductionPregnancy outcomesSpontaneous mensesInfertility patientsCase seriesMedian timeOvulatory responseMAIN OUTCOMESide effectsPatientsMetformin
1999
Fertilization after standard in vitro fertilization versus intracytoplasmic sperm injection in subfertile males using sibling oocytes
Pisarska M, Casson P, Cisneros P, Lamb D, Lipshultz L, Buster J, Carson S. Fertilization after standard in vitro fertilization versus intracytoplasmic sperm injection in subfertile males using sibling oocytes. Fertility And Sterility 1999, 71: 627-632. PMID: 10202870, DOI: 10.1016/s0015-0282(98)00538-x.Peer-Reviewed Original ResearchConceptsSevere teratozoospermiaEmbryo qualityConventional IVFGroup AMale populationMean percentIntracytoplasmic sperm injectionProspective experimental studyFertilization rateIVF cyclesICSI cyclesOvulation inductionGroup BICSI resultsMore abnormalitiesMAIN OUTCOMESperm injectionIVFICSIIVF clinicsSubfertile malesHigher fertilization rateRandom allocationTeratozoospermiaSignificant differences
1998
Postmenopausal dehydroepiandrosterone administration increases free insulin-like growth factor-I and decreases high-density lipoprotein: a six-month trial
Casson P, Santoro N, Elkind-Hirsch K, Carson S, Hornsby P, Abraham G, Buster J. Postmenopausal dehydroepiandrosterone administration increases free insulin-like growth factor-I and decreases high-density lipoprotein: a six-month trial. Fertility And Sterility 1998, 70: 107-110. PMID: 9660430, DOI: 10.1016/s0015-0282(98)00121-6.Peer-Reviewed Original ResearchConceptsHigh-density lipoproteinInsulin-like growth factorLevels of DHEADHEA therapySerum DHEAImmune indicesFree insulin-like growth factorDual-energy X-ray absorptiometry scanX-ray absorptiometry scansA1 levelsGrowth factorLiver function testsInsulin-sensitizing propertiesRatio of IGFSmall study sizeSix-month trialPostdose levelsPremenopausal rangePostmenopausal womenIGFBP-3Function testsInsulin sensitivityReferral practicesParallel trialMAIN OUTCOMEHeterotopic abdominal pregnancy treated at laparoscopy
Pisarska M, Casson P, Moise K, DiMaio D, Buster J, Carson S. Heterotopic abdominal pregnancy treated at laparoscopy. Fertility And Sterility 1998, 70: 159-160. PMID: 9660440, DOI: 10.1016/s0015-0282(98)00104-6.Peer-Reviewed Original ResearchConceptsHeterotopic abdominal pregnancyAbdominal pregnancyIVF-ETConcurrent intrauterine pregnancyIntrauterine pregnancyLaparoscopic treatmentHuman chorionic gonadotropin levelsEctopic abdominal pregnancyPrimary abdominal pregnancyPelvic ultrasound examinationChorionic gonadotropin levelsSuccessful laparoscopic treatmentAbdominal gestationLuteal supportIntrauterine gestationOvulation inductionGonadotropin levelsPathologic findingsIVF programCase reportUltrasound examinationEarly diagnosisMAIN OUTCOMEPregnancyLaparoscopyLack of Association Between Antiphospholipid Antibodies and First-Trimester Spontaneous Abortion: Prospective Study of Pregnancies Detected Within 21 Days of Conception 11Supported by grants and contracts from the National Institute of Child Health and Human Development, National Institutes of Health.
Simpson J, Carson S, Chesney C, Conley M, Metzger B, Aarons J, Holmes L, Jovanovic-Peterson L, Knopp R, Mills J. Lack of Association Between Antiphospholipid Antibodies and First-Trimester Spontaneous Abortion: Prospective Study of Pregnancies Detected Within 21 Days of Conception 11Supported by grants and contracts from the National Institute of Child Health and Human Development, National Institutes of Health. Fertility And Sterility 1998, 69: 814-820. PMID: 9591485, DOI: 10.1016/s0015-0282(98)00054-5.Peer-Reviewed Original ResearchConceptsAntiphospholipid antibodiesAnticardiolipin antibodiesPregnancy lossProspective studyFirst trimester pregnancy lossEnzyme immunoassayFirst-trimester spontaneous abortionsFirst trimester lossNational InstituteLack of associationDay of conceptionFetal deathRetrospective studySpontaneous abortionLive birthsMAIN OUTCOMEChild healthSuch antibodiesBlood samplesPregnancyMulticenter universityAntibodiesSerumWomenSelection bias
1996
Single serum progesterone as a screen for ectopic pregnancy: exchanging specificity and sensitivity to obtain optimal test performance*
McCord M, Muram D, Buster J, Arheart K, Stovall T, Carson S. Single serum progesterone as a screen for ectopic pregnancy: exchanging specificity and sensitivity to obtain optimal test performance*. Fertility And Sterility 1996, 66: 513-516. PMID: 8816609, DOI: 10.1016/s0015-0282(16)58560-4.Peer-Reviewed Original ResearchConceptsViable intrauterine pregnancyEctopic pregnancyIntrauterine pregnancySpontaneous abortionDiagnostic accuracyCutoff valueFirst trimester pregnant womenSingle serum progesteroneInvasive diagnostic studiesTrimester pregnant womenHigh diagnostic accuracyPregnant womenSerum PSerum progesteroneUniversity HospitalRetrospective analysisMAIN OUTCOMEPregnancy